Home NRBO
1.57
  Price9.79%   +0.14
(After Hours: 1.54 -0.03 -1.91%)
loading

Neurobo Pharmaceuticals (NRBO) Options Chain

Calls Options of NRBO for 2022-12-16 (Expired in 11 days)

Strike Price Change % Change Volume
favorite 0 0.00 0.00 0.00% 0
favorite 0 0.00 0.00 0.00% 0
favorite 0 0.00 0.00 0.00% 0
favorite 2.50 0.05 0.00 0.00% 0
favorite 5.00 0.00 0.00 0.00% 0
favorite 7.50 0.00 0.00 0.00% 0

Puts Options of NRBO for (Expired in 11 days)

Strike Price Change % Change Volume
favorite
0
0.00 0.00 0.00% 0
favorite
0
0.00 0.00 0.00% 0
favorite
0
0.00 0.00 0.00% 0
favorite
2.50
0.00 0.00 0.00% 0
favorite
5.00
0.00 0.00 0.00% 0
favorite
7.50
0.00 0.00 0.00% 0
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Cap:    |  Volume (24h):